Federation Des Caisses Desjardins Du Quebec Intra Cellular Therapies, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 305 shares of ITCI stock, worth $25,958. This represents 0.0% of its overall portfolio holdings.
Number of Shares
305
Previous 305
-0.0%
Holding current value
$25,958
Previous $20,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
378Shares Held
84.7MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$819 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$538 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$450 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$328 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$260 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.03B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...